The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Blockade of interleukin‐6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury
Abstract
Endogenous neural stem/progenitor cells (NSPCs) have recently been shown to differentiate exclusively into astrocytes, the cells that are involved in glial scar formation after spinal cord injury (SCI). The microenvironment of the spinal cord, especially the inflammatory cytokines that dramatically increase in the acute phase at the injury site, is considered to be an important cause of inhibitory mechanism of neuronal differentiation following SCI. Interleukin‐6 (IL‐6), which has been demonstrated to induce NSPCs to undergo astrocytic differentiation selectively through the JAK/STAT pathway in vitro, has also been demonstrated to play a critical role as a proinflammatory cytokine and to be associated with secondary tissue damage in SCI. In this study, we assessed the efficacy of rat anti‐mouse IL‐6 receptor monoclonal antibody (MR16‐1) in the treatment of acute SCI in mice. Immediately after contusive SCI with a modified NYU impactor, mice were intraperitoneally injected with a single dose of MR16‐1 (100 μg/g body weight), the lesions were assessed histologically, and the functional recovery was evaluated. MR16‐1 not only suppressed the astrocytic diffentiation‐promoting effect of IL‐6 signaling in vitro but inhibited the development of astrogliosis after SCI in vivo. MR16‐1 also decreased the number of invading inflammatory cells and the severity of connective tissue scar formation. In addition, we observed significant functional recovery in the mice treated with MR16‐1 compared with control mice. These findings suggest that neutralization of IL‐6 signaling in the acute phase of SCI represents an attractive option for the treatment of SCI. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357
Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System
Johansson, C. B., Momma, S., Clarke, D. L., Risling, M., Lendahl, U., & Frisén, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80956-3 · Cited by 1,875
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803
A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes
Reynolds, B., Tetzlaff, W., & Weiss, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04565.1992 · Cited by 1,509
Basso, D. M., Beattie, M. S., & Bresnahan, J. C. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0098 · Cited by 1,470
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Self-citationBracken, M. B. (1997) · JAMA · doi:10.1001/jama.277.20.1597 · Cited by 1,397
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Self-citationAtreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationBracken, M. B. (1997) · JAMA · doi:10.1001/jama.1997.03540440031029 · Cited by 1,194
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway
Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D. A., Rozovsky, I., Stahl, N., Yancopoulos, G. D., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.278.5337.477 · Cited by 1,013
Synergistic Signaling in Fetal Brain by STAT3-Smad1 Complex Bridged by p300
Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Miyazono, K., & Taga, T. (1999) · Science · doi:10.1126/science.284.5413.479 · Cited by 865
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Self-citationProliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord
Horner, P. J., Power, A. E., Kempermann, G., Kuhn, H. G., Palmer, T. D., Winkler, J., Thal, L. J., & Gage, F. H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02218.2000 · Cited by 777
A Monitored Contusion Model of Spinal Cord Injury in the Rat
GRUNER, J. A. (1992) · Journal of Neurotrauma · doi:10.1089/neu.1992.9.123 · Cited by 747
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526 · cited 1×
“…IL-6R (MRA; Atlizumab) has already been reshaped (Sato et al., 1993), and its therapeutic efficacy has been confirmed in clinical trials in several diseases, including rheumatoid arthritis, Castleman’s disease, and multiple myeloma (Sato et al., 1993; Nishimoto et al., 2000; Choy et al., 2002).”
BackgroundSelf-citationAcute Inflammatory Response in Spinal Cord Following Impact Injury
Carlson, S. L., Parrish, M. E., Springer, J. E., Doty, K., & Dossett, L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6785 · Cited by 496
Noble, L. J., Donovan, F., Igarashi, T., Goussev, S., & Werb, Z. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07526.2002 · Cited by 494
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Self-citationCerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the Rat
Loddick, S. A., Turnbull, A. V., & Rothwell, N. J. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199802000-00008 · Cited by 418
BETHEA, J. R., NAGASHIMA, H., ACOSTA, M. C., BRICENO, C., GOMEZ, F., MARCILLO, A. E., LOOR, K., GREEN, J., & DIETRICH, W. D. (1999) · Journal of Neurotrauma · doi:10.1089/neu.1999.16.851 · Cited by 401
Gorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., Di Giulio, A. M., Vardar, E., Cerami, A., & Brines, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142287899 · Cited by 389
Interleukin-6 expression and regulation in astrocytes
Van Wagoner, N. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00187-3 · Cited by 363
Sympathetic neurons can produce and respond to interleukin 6
März, P., Cheng, J.-G., Gadient, R. A., Patterson, P. H., Stoyan, T., Otten, U., & Rose-John, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3251 · Cited by 332
Hirota, H., Kiyama, H., Kishimoto, T., & Taga, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2627 · Cited by 321
Self-citationKernie, S. G., Erwin, T. M., & Parada, L. F. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10013 · Cited by 299
Impaired neuroglial activation in interleukin-6 deficient mice
Klein, M. A., M�ller, J. C., Jones, L. L., Bluethmann, H., Kreutzberg, G. W., & Raivich, G. (1997) · Glia · doi:10.1002/(sici)1098-1136(199703)19:3<227::aid-glia5>3.0.co;2-w · Cited by 289
Shimazaki, T., Shingo, T., & Weiss, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07642.2001 · Cited by 288
Self-citationStem cell biology of the central nervous system
Okano, H. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10343 · Cited by 280
Self-citationModulating astrogliosis after neurotrauma
McGraw, J., Hiebert, G. W., & Steeves, J. D. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010115)63:2<109::aid-jnr1002>3.0.co;2-j · Cited by 276
Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
Sato, K., Tsuchiya, M., Saldanha, J. W., Koishihara, Y., Ohsugi, Y., Kishimoto, T., & Bendig, M. M. (1993) · PubMed · Cited by 274
Self-citationBlockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis
Takagi, N., Mihara, M., Moriya, Y., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Takeda, Y., & Ohsugi, Y. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2117::aid-art6>3.0.co;2-p · Cited by 270
Self-citationDissection of Signaling Cascades through gp130 In Vivo
Ohtani, T., Ishihara, K., Atsumi, T., Nishida, K., Kaneko, Y., Miyata, T., Itoh, S., Narimatsu, M., Maeda, H., Fukada, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80162-4 · Cited by 243
Self-citationMa, M., Basso, D. M., Walters, P., Stokes, B. T., & Jakeman, L. B. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7679 · Cited by 241
Traumatic Spinal Cord Injury Produced by Controlled Contusion in Mouse
JAKEMAN, L. B., GUAN, Z., WEI, P., PONNAPPAN, R., DZWONCZYK, R., POPOVICH, P. G., & STOKES, B. T. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.299 · Cited by 209
Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics
Popovich, P. G., & Jones, T. B. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00006-8 · Cited by 200
Effects of pro-inflammatory cytokines in experimental spinal cord injury
Klusman, I., & Schwab, M. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00381-8 · Cited by 197
Yan, H. Q., Banos, M. A., Herregodts, P., Hooghe, R., & Hooghe‐Peters, E. L. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221131 · Cited by 195
M OLECULAR A PPROACHES TO S PINAL C ORD R EPAIR
David, S., & Lacroix, S. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094946 · Cited by 192
Nakamura, M., Houghtling, R. A., MacArthur, L., Bayer, B. M., & Bregman, B. S. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00361-3 · Cited by 187
Self-citationTransplantation of neural stem cells into the spinal cord after injury
Okano, H., Ogawa, Y., Nakamura, M., Kaneko, S., Iwanami, A., & Toyama, Y. (2003) · Seminars in Cell & Developmental Biology · doi:10.1016/s1084-9521(03)00011-9 · Cited by 167
Self-citationPan, J. Z., Ni, L., Sodhi, A., Aguanno, A., Young, W., & Hart, R. P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10215 · Cited by 150
Lacroix, S., Chang, L., Rose‐John, S., & Tuszynski, M. H. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10407 · Cited by 140
A Mouse Model of Graded Contusive Spinal Cord Injury
Kuhn, P. L., & Wrathall, J. R. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.125 · Cited by 135
Katsume, A., Saito, H., Yamada, Y., Yorozu, K., Ueda, O., Akamatsu, K.-I., Nishimoto, N., Kishimoto, T., Yoshizaki, K., & Ohsugi, Y. (2002) · Cytokine · doi:10.1006/cyto.2002.2012 · Cited by 134
Self-citationLeskovar, A., Moriarty, L. J., Turek, J. J., Schoenlein, I. A., & Borgens, R. B. (2000) · Journal of Experimental Biology · doi:10.1242/jeb.203.12.1783 · Cited by 134
Matsuda, S., Wen, T., Morita, F., Otsuka, H., Igase, K., Yoshimura, H., & Sakanaka, M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12340-5 · Cited by 112
Characterization of anti-mouse interleukin-6 receptor antibody
Okazaki, M., Yamada, Y., Nishimoto, N., Yoshizaki, K., & Mihara, M. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00202-x · Cited by 108
Self-citationBjörklund, A., & Lindvall, O. (2000) · Nature · doi:10.1038/35016175 · Cited by 96
Ependymal Cell Reactions in Spinal Cord Segments after Compression Injury in Adult Rat
Takahashi, M., Arai, Y., Kurosawa, H., Sueyoshi, N., & Shirai, S.-I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.185 · Cited by 87
Mayeux, P., Dusanter‐Fourt, I., Muller, O., Mauduit, P., Sabbah, M., Druker, B. J., Vainchenker, W., FISCHER, S., Lacombe, C., & Gisselbrecht, S. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18203.x · Cited by 84
Shimosato, K., & Ohkuma, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00185-4 · Cited by 66
Ogura, H., Matsumoto, M., & Mikoshiba, K. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00187-5 · Cited by 65
Astrocytic Alterations in Interleukin-6/Soluble Interleukin-6 Receptor α Double-Transgenic Mice
Brunello, A., Weissenberger, J., Каппелер, А., Vallan, C., Peters, M., Rose‐John, S., & Weis, J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64787-6 · Cited by 64
Tuna, M., Polat, S., Erman, T., İldan, F., Göçer, A. İ., Tuna, N., Tamer, L., Kaya, M., & Çetinalp, E. (2001) · Journal of Neurosurgery Spine · doi:10.3171/spi.2001.95.1.0064 · Cited by 50
Meima, L., Moran, P., Matthews, W., & Caras, I. W. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0621 · Cited by 46
PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury
Hostettler, M. E., & Carlson, S. L. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00009 · Cited by 29
Cited by
Donnelly, D. J., & Popovich, P. G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.009 · Cited by 995
Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury
Hains, B. C., & Waxman, S. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0003-06.2006 · Cited by 640
Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses
Orr, M. B., & Gensel, J. C. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0631-6 · Cited by 583
Transplantation of human neural stem cells for spinal cord injury in primates
Iwanami, A., Kaneko, S., Nakamura, M., Kanemura, Y., Mori, H., Kobayashi, S., Yamasaki, M., Momoshima, S., Ishii, H., Ando, K., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20436 · Cited by 387
Self-citationDealing with danger in the CNS: the response of the immune system to injury
Gadani, S. P., Walsh, J. T., Lukens, J. R., & Kipnis, J. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.019 · Cited by 342
Metadata
- Authors
- Okada, S., Nakamura, M., Mikami, Y., Shimazaki, T., Mihara, M., Ohsugi, Y., Iwamoto, Y., Yoshizaki, K., Kishimoto, T., Toyama, Y., & Okano, H.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2004-03-08
- Volume
- 76
- Issue
- 2
- Pages
- 265-276
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2013683961
- Cited by
- 264
- References
- 58
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.